Inventiva S.A. (NASDAQ:IVA) is one of the best strong buy penny stocks to invest in now. Inventiva S.A. (NASDAQ:IVA) announced on July 9 the completion of the final step of the transactions previously announced on June 2, 2026, through the issuance of approximately 15.7 million new warrants to the European Investment Bank, along with the […]

By Karen Roman Inventiva S.A. (Nasdaq: IVA) said Axel-Sven Malkomes joined the company as Chief Financial Officer, while Susan Coles and Pamela Herbster started their roles as Chief Legal Officer and Chief People Officer, respectively. The additions come as Inventiva prepares for potential commercialization from the Phase 3 trial of its MASH therapeutic, expected in […]

Inventiva’s updated analyst narrative now reflects a Fair Value move from €8.98 to about €10.00, a shift that aligns with the refreshed price target range highlighted in recent research. This reset sits against a backdrop of contrasting views on how effectively lanifibranor can progress through later stages and what that could mean for the company’s overall appeal within small to mid cap biotech coverage. Read on to see how to track these changing views and what to watch as the story...